pharmaceutical investing AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
pharmaceutical investing AbbVie Submits Application to FDA for Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
pharmaceutical investing RINVOQ® Demonstrated Superiority Versus HUMIRA® for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF inhibitor
pharmaceutical investing EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie
pharmaceutical investing AbbVie Submits Regulatory Application to FDA for SKYRIZI® Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
pharmaceutical investing AbbVie Provides Update on TrenibotulinumtoxinE Biologics License Application in the U.S.
pharmaceutical investing AbbVie Showcases Late?Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx in Platinum?Sensitive Ovarian Cancer at SGO 2026
pharmaceutical investing BOTOX® Cosmetic Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year
pharmaceutical investing BOTOX® Cosmetic Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year
